Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Transcriptome sequencing of malignant pleural mesothelioma tumors

Open access

Abstract

Cancers arise by the gradual accumulation of mutations in multiple genes. We now use shotgun pyrosequencing to characterize RNA mutations and expression levels unique to malignant pleural mesotheliomas (MPMs) and not present in control tissues. On average, 266 Mb of cDNA were sequenced from each of four MPMs, from a control pulmonary adenocarcinoma (ADCA), and from normal lung tissue. Previously observed differences in MPM RNA expression levels were confirmed. Point mutations were identified by using criteria that require the presence of the mutation in at least four reads and in both cDNA strands and the absence of the mutation from sequence databases, normal adjacent tissues, and other controls. In the four MPMs, 15 nonsynonymous mutations were discovered: 7 were point mutations, 3 were deletions, 4 were exclusively expressed as a consequence of imputed epigenetic silencing, and 1 was putatively expressed as a consequence of RNA editing. Notably, each MPM had a different mutation profile, and no mutated gene was previously implicated in MPM. Of the seven point mutations, three were observed in at least one tumor from 49 other MPM patients. The mutations were in genes that could be causally related to cancer and included XRCC6 , PDZK1IP1 , ACTR1A , and AVEN .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0712399105

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 2

  1. 10.1002/1098-2264(200007)28:3<337::AID-GCC12>3.0.CO;2-B · doi:10.1002/1098-2264(200007)28:3<337::aid-gcc12>3.0.co;2-b
  2. 10.1016/S1097-2765(05)00021-3 · DOI · Paper page

Cited by

See all 155

Metadata

Authors
Sugarbaker, D. J., Richards, W. G., Gordon, G. J., Dong, L., De Rienzo, A., Maulik, G., Glickman, J. N., Chirieac, L. R., Hartman, M.-L., Taillon, B. E., Du, L., Bouffard, P., Kingsmore, S. F., Miller, N. A., Farmer, A. D., Jensen, R. V., Gullans, S. R., & Bueno, R.
Affiliations
  • *International Mesothelioma Program,
  • Brigham and Women's Hospital (US)
  • 454 Life Sciences, Inc., 20 Commercial Street, Branford, CT 06405;
  • National Center for Genome Resources (US)
  • Virginia Tech (US)
  • RxGen, Inc., 100 Deepwood Drive, Hamden, CT 06517
Venue
Proceedings of the National Academy of Sciences
Published
2008-03-04
Volume
105
Issue
9
Pages
3521-3526
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2084180192
Cited by
155
References
47
Citations by year
2024: 3 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 6 · 2012: 11
FWCI
24.48
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
Funders
National Cancer Institute (R21/R33 CA 100315, P20CA9057801-A1, U01 CA65170-07, CA65170, R33CA100315, R21CA100315, U24CA114725, U01CA065170, R01CA120528)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
malignant pleural mesothelioma, tumor transcriptome, RNA mutations, point mutations, non-synonymous mutations, RNA editing, epigenetic silencing, tumor-specific gene expression, Ku70, PDZK1IP1, Aven
MeSH terms
Ku Autoantigen, DNA-Binding Proteins, Humans, Membrane Proteins, Mesothelioma, Mutation, Neoplasm Proteins, Pleural Neoplasms, RNA, Neoplasm, Gene Expression Regulation, Neoplastic, Point Mutation, Sequence Deletion, RNA Editing, Gene Silencing, Gene Expression Profiling, Activin Receptors, Type I, Antigens, Nuclear, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcriptome sequencing of malignant pleural mesothelioma tumors. https://app.cochat.ai/papers/10.1073/pnas.0712399105
The paper
Sugarbaker, D. J., Richards, W. G., Gordon, G. J., Dong, L., De Rienzo, A., Maulik, G., Glickman, J. N., Chirieac, L. R., Hartman, M.-L., Taillon, B. E., Du, L., Bouffard, P., Kingsmore, S. F., Miller, N. A., Farmer, A. D., Jensen, R. V., Gullans, S. R., & Bueno, R. (2008). Transcriptome sequencing of malignant pleural mesothelioma tumors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0712399105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.